Fisher & Paykel Healthcare Inc Fisher & Paykel FlexiFit Full Face Mask, Part Numbers: HC 431A, HC431SLL, HC431SLM & HC431SLS. CPAP masks. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Fisher & Paykel FlexiFit Full Face Mask, Part Numbers: HC 431A, HC431SLL, HC431SLM & HC431SLS. CPAP masks.
Brand
Fisher & Paykel Healthcare Inc
Lot Codes / Batch Numbers
Lot numbers for Part Numbers 431A (lot #s: 031120 to 051121), HC431SLL (lot #s: 050607 to 051028), HC431SLM (lot #s: 050609 to 051107) & HC431SLS (lot #s: 050609 to 051107)
Products Sold
Lot numbers for Part Numbers 431A (lot #s: 031120 to 051121), HC431SLL (lot #s: 050607 to 051028), HC431SLM (lot #s: 050609 to 051107) & HC431SLS (lot #s: 050609 to 051107)
Fisher & Paykel Healthcare Inc is recalling Fisher & Paykel FlexiFit Full Face Mask, Part Numbers: HC 431A, HC431SLL, HC431SLM & HC431SLS. CP due to Plastic tabs incorporated into the connector components of these CPAP masks may break off if they are not cleaned in accordance with the Instructions . Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Plastic tabs incorporated into the connector components of these CPAP masks may break off if they are not cleaned in accordance with the Instructions for Use. In the event of a tab breaking off, it may enter the CPAP system air path and there is an extremely remote possibility that the broken tab may then enter the patient's nasal cavity or mouth. Masks manufactured since April 2006 do not featu
Recommended Action
Per FDA guidance
Fisher & Paykel Healthcare Inc. commenced sending out letters by mail to consignees the week commencing 4 December 2006 advising consignees to quarantine and destroy affected product. A faxback form was also be provided for consignees to advise Fisher & Paykel Healthcare of quarantined and destroyed stock. The firm will supply consignees with replacement product as determined from completed faxback information. The firm will collate responses from consignees and will follow up with a letter to consignees who do not respond within a month of initial mail-out. The firm will then make telephone contact with any consignees who do not respond within a month of the second mail-out. Fisher & Paykel Healthcare Inc. estimated the completion of this voluntary recall by April 2007.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026